Search
Research
Age at diagnosis of birth defectsMany birth defects surveillance programs ascertain cases of birth defects diagnosed beyond 1 year of age.
Research
Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group studyContinuous complete clinical remission in T-cell acute lymphoblastic leukemia (T-ALL) is now approaching 80% due to the implementation of aggressive...
Research
Exposure to non-core foods and beverages in the first year of life: Results from a cohort studyTo report the proportion of Australian infants who were introduced to non-core foods and beverages and to identify associated factors
Research
Type 1 diabetes in children - emergency managementFifteen to sixty-seven percent of patients with new onset type 1 diabetes mellitus (T1DM) present in diabetic ketoacidosis (DKA), of which approximately...
Research
Hypoallergenic der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergyMore than 50% of allergic patients have house dust mite (HDM) allergy.
Research
Locally derived traffic-related air pollution and fetal growth restriction: a retrospective cohort studyFetal growth restriction has been inconsistently associated with maternal exposure to elevated levels of traffic-related air pollution.
Research
Attitudes and behaviour predict women's intention to drink alcohol during pregnancy:To explore women's alcohol consumption in pregnancy, and potential predictors of alcohol consumption in pregnancy.
Research
Nasopharyngeal carriage of Streptococcus pneumoniae: prevalence and risk factors in HIV-positive children in TanzaniaPneumococcal colonization of the nasopharynx is especially common in young children and is a pre-requisite for pneumococcal disease...
Research
In utero hypertensive diseases and cognition in offspring into old ageHypertensive diseases of pregnancy including gestational hypertension and preeclampsia continue to pose a major obstetric risk,...
Research
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 yearsWe present further data on vaccine efficacy (VE) against HPV-16/18 in the total vaccinated cohort including women who may have been exposed to HPV-16/18...